Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell Carcinoma.
Saved in:
| Title: | Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell Carcinoma. |
|---|---|
| Authors: | Riaza Montes M; Department of Urology, Galdakao-Usansolo University Hospital, 48960 Usansolo, Spain.; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain., Suárez B; Department of Nursing, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Solano-Iturri JD; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; Pathology Department, Cruces University Hospital, 48903 Barakaldo, Spain., Lecumberri D; Department of Urology, Cruces University Hospital, 48903 Barakaldo, Spain., Iturregui AM; Department of Urology, Cruces University Hospital, 48903 Barakaldo, Spain., Lawrie CH; Molecular Oncology Group, Biogipuzkoa Health Research Institute, 20014 San Sebastián, Spain.; IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain.; Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, UK.; Sino-Swiss Institute of Advanced Technology (SSIAT), Shanghai University, Shanghai 201800, China., Armesto M; Molecular Oncology Group, Biogipuzkoa Health Research Institute, 20014 San Sebastián, Spain., Nunes-Xavier CE; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0424 Oslo, Norway., Pulido R; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain., López JI; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain., Angulo JC; Department of Urology, Hospital Universitario de Getafe, 28907 Getafe, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, 28670 Madrid, Spain., Larrinaga G; Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.; Department of Nursing, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2025 Nov 17; Vol. 26 (22). Date of Electronic Publication: 2025 Nov 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1422-0067 |
|---|---|
| DOI: | 10.3390/ijms262211112 |
